SCHEDULE 13D

Company

LIGAND PHARMACEUTICALS INC

Filed

May 21, 1998

Accession Number

0000936392-98-000869

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →